Literature DB >> 29383647

Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).

Lei Qin1,2, Angie Li3,4, Jinrong Qu3,5, Katherine Reinshagen2,3,6, Xiang Li3,5, Su-Chun Cheng7, Annie Bryant1,8, Geoffrey S Young9,10,11.   

Abstract

Mixed reports leave uncertainty about whether normalization of apparent diffusion coefficient (ADC) to a within-subject white matter reference is necessary for assessment of tumor cellularity. We tested whether normalization improves the previously reported correlation of resection margin ADC with 15-month overall survival (OS) in HGG patients. Spin-echo echo-planar DWI was retrieved from 3 T MRI acquired between maximal resection and radiation in 37 adults with new-onset HGG (25 glioblastoma; 12 anaplastic astrocytoma). ADC maps were produced with the FSL DTIFIT tool (Oxford Centre for Functional MRI). 3 neuroradiologists manually selected regions of interest (ROI) in normal appearing white matter (NAWM) and in non-enhancing tumor (NT) < 2 cm from the margin of residual enhancing tumor or resection cavity. Normalized ADC (nADC) was computed as the ratio of absolute NT ADC to NAWM ADC. Reproducibility of nADC and absolute ADC among the readers' ROI was assessed using intra-class correlation coefficient (ICC) and within-subject coefficient of variation (wCV). Correlations of ADC and nADC with OS were compared using receiver operating characteristics (ROC) analysis. A p value 0.05 was considered statistically significant. Both mean ADC and nADC differed significantly between patients subgrouped by 15-month OS (p = 0.0014 and 0.0073 respectively). wCV and ICC among the readers were similar for absolute and normalized ADC. In ROC analysis of correlation with OS, nADC did not perform significantly better than absolute ADC. Normalization does not significantly improve the correlation of absolute ADC with OS in HGG, suggesting that normalization is not necessary for clinical or research ADC analysis in HGG patients.

Entities:  

Keywords:  ADC normalization; Apparent diffusion coefficient (ADC); Diffusion weighted imaging (DWI); High-grade glioma (HGG)

Mesh:

Year:  2018        PMID: 29383647      PMCID: PMC6071871          DOI: 10.1007/s11060-017-2719-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

2.  Normalized Apparent Diffusion Coefficient in the Prognostication of Patients with Glioblastoma Multiforme.

Authors:  Jai Jai Shiva Shankar; Adil Bata; Krista Ritchie; Andrea Hebb; Simon Walling
Journal:  Can J Neurol Sci       Date:  2016-01       Impact factor: 2.104

3.  Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.

Authors:  Andrew Elson; Joseph Bovi; Malika Siker; Chris Schultz; Eric Paulson
Journal:  J Neurooncol       Date:  2015-02-21       Impact factor: 4.130

4.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.

Authors:  Ryuji Murakami; Takeshi Sugahara; Hideo Nakamura; Toshinori Hirai; Mika Kitajima; Yoshiko Hayashida; Yuji Baba; Natsuo Oya; Jun-Ichi Kuratsu; Yasuyuki Yamashita
Journal:  Radiology       Date:  2007-03-13       Impact factor: 11.105

5.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

6.  Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets.

Authors:  Huiman X Barnhart; Daniel P Barboriak
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.

Authors:  Joonmi Oh; Roland G Henry; Andrea Pirzkall; Ying Lu; Xiaojuan Li; Isabelle Catalaa; Susan Chang; William P Dillon; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2004-05       Impact factor: 4.813

8.  Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

Authors:  Hideo Nakamura; Ryuji Murakami; Toshinori Hirai; Mika Kitajima; Yasuyuki Yamashita
Journal:  Acta Radiol       Date:  2012-11-08       Impact factor: 1.990

9.  Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain.

Authors:  Matthew Grech-Sollars; Patrick W Hales; Keiko Miyazaki; Felix Raschke; Daniel Rodriguez; Martin Wilson; Simrandip K Gill; Tina Banks; Dawn E Saunders; Jonathan D Clayden; Matt N Gwilliam; Thomas R Barrick; Paul S Morgan; Nigel P Davies; James Rossiter; Dorothee P Auer; Richard Grundy; Martin O Leach; Franklyn A Howe; Andrew C Peet; Chris A Clark
Journal:  NMR Biomed       Date:  2015-04       Impact factor: 4.044

10.  Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics.

Authors:  Daniel Rodriguez Gutierrez; Muftah Manita; Tim Jaspan; Robert A Dineen; Richard G Grundy; Dorothee P Auer
Journal:  Neuro Oncol       Date:  2013-04-12       Impact factor: 12.300

View more
  4 in total

1.  Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.

Authors:  W Han; L Qin; C Bay; X Chen; K-H Yu; N Miskin; A Li; X Xu; G Young
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-19       Impact factor: 3.825

2.  Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.

Authors:  Akifumi Hagiwara; Talia C Oughourlian; Nicholas S Cho; Jacob Schlossman; Chencai Wang; Jingwen Yao; Catalina Raymond; Richard Everson; Kunal Patel; Sergey Mareninov; Fausto J Rodriguez; Noriko Salamon; Whitney B Pope; Phioanh L Nghiemphu; Linda M Liau; Robert M Prins; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

3.  MRI-based radiomics to predict response in locally advanced rectal cancer: comparison of manual and automatic segmentation on external validation in a multicentre study.

Authors:  Arianna Defeudis; Simone Mazzetti; Jovana Panic; Monica Micilotta; Lorenzo Vassallo; Giuliana Giannetto; Marco Gatti; Riccardo Faletti; Stefano Cirillo; Daniele Regge; Valentina Giannini
Journal:  Eur Radiol Exp       Date:  2022-05-03

4.  Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.

Authors:  Chae Jung Park; Yoon Seong Choi; Yae Won Park; Sung Soo Ahn; Seok-Gu Kang; Jong-Hee Chang; Se Hoon Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2019-12-09       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.